The field of bioprinting holds great promise for human health. Health Research BC awardee, Dr. Stephanie Willerth’s innovative work in this area will ultimately improve health outcomes for people with neurological diseases.
News Award Type: Innovation to Commercialization Program
A 20-year journey of health research in BC: Partnering to invest in BCâs researchers, teams and networks
For over 15 years, MSFHR, Praxis Spinal Cord Institute and ICORD have partnered to support health researchers in BC who have collectively revolutionized the field of spinal cord research.
MSFHR funds 19 innovators to advance made-in-BC health research and discoveries for improved patient care
The 2020 Innovation to Commercialization and Health Professional-Investigator awardees are applying research and innovations to improve health outcomes for British Columbians.
MSFHRâs 2021 Suite of Funding Opportunities Will Enable Innovative Health Research Across BC
By investing in and supporting health research, we are continuing to support British Columbians through the pandemic and our provinceâs economic recovery.
Shining a (near-infrared) light on spinal cord injury treatment
Dr. Brian Kwon and his research team are using MSFHR funding to advance a novel technology to improve outcomes for patients with spinal cord injury.
Continue reading “Shining a (near-infrared) light on spinal cord injury treatment”
MSFHR and Mitacs partnership unlocks additional funding for applicants
MSFHR and Mitacs have partnered to support joint applications so researchers can access both Mitacs and MSFHR funding with one application.
Continue reading “MSFHR and Mitacs partnership unlocks additional funding for applicants”
MSFHR funds nine BC health researchers moving innovations towards practical application
Nine BC health researchers have been funded in MSFHRâs third Innovation to Commercialization (I2C) competition.
Continue reading “MSFHR funds nine BC health researchers moving innovations towards practical application”
MSFHR-funded research identifies enzyme potentially responsible for skin blistering
2003 Scholar and 2017 I2C award recipient Dr. David Granville has identified an enzyme potentially responsible for skin blistering, and is developing an inhibitor to prevent and treat the condition.
MSFHR funds eight BC health researchers moving innovations towards practical application
Eight BC health researchers have been funded in MSFHRâs second Innovation to Commercialization competition.
MSFHR-funded researcher discovers a new drug that could stop prostate cancer in its tracks
Christopher Ong says his 2017 I2C award came at an opportune time in the development of a new drug that could stop prostate cancer in its tracks.